Purchase Order 70Z03424PHONO0077
Award Date 1/29/24
Potential Completion Date 1/29/24
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Honolulu, HI 96819, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the U.S. Coast Guard to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, to provide NARCAN nasal spray. The contract has a ceiling value of $99,908.04 and a completion date of September 13, 2024. Emergent Devices is the prime contractor and there are no set-aside designations mentioned. Emergent Devices is a subsidiary of Emergent BioSolutions and specializes in providing medical countermeasures, particularly naloxone...
- The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...
- This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
- This federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, is for the provision of pharmaceuticals, specifically NARCAN nasal spray and other naloxone products, to various U.S. government agencies. The $226,140.00 Firm Fixed Price delivery order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 and has a completion date of January 13, 2017. Emergent Devices holds two significant federal contract vehicles - an $11.8...
- This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not...
- This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices. The $904,465.44 contract is for the delivery of NALOXONE HCL 4MG/SPRAY, a medication that rapidly reverses opioid overdose and treats substance abuse. This delivery order was competed on the VHA's Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which Emergent Devices holds...
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the delivery of naloxone nasal spray. The contract, valued at $904,465.44, was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract is a delivery order under Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. Naloxone is a medication used to...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Emergent Devices, Inc. for the provision of naloxone nasal spray. The contract is a Firm Fixed Price Delivery Order with a potential value of $292,572.00. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, is the prime contractor on this award. The contract is not set aside and is issued under the...
- This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The contract is a $934,875.00 delivery order under Emergent Devices' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which runs through August 2028. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has also received other...
- This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs for NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $130,256.64 and is a Firm Fixed Price Delivery Order. It is not a set-aside contract. Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds multiple...